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Abstract
There are advantages to conducting cardiovascular magnetic resonance (CMR) studies at a field strength of 3.0
Telsa, including the increase in bulk magnetization, the increase in frequency separation of off-resonance spins, and
the increase in T1 of many tissues. However, there are significant challenges to routinely performing CMR at 3.0T,
including the reduction in main magnetic field homogeneity, the increase in RF power deposition, and the
increase in susceptibility-based artifacts.
In this review, we outline the underlying physical effects that occur when imaging at higher fields, examine the
practical results these effects have on the CMR applications, and examine methods used to compensate for these
effects. Specifically, we will review cine imaging, MR coronary angiography, myocardial perfusion imaging, late
gadolinium enhancement, and vascular wall imaging.
Introduction
Three Tesla (3.0T) magnetic resonance imaging (MRI)
scanners have been approved for use by the United
States Food and Drug Administration (US FDA) since
1999 for head imaging and since 2001 for whole body
imaging. 3.0T systems have become the standard for
neurological imaging at many institutions [1-3]. The
adoption of 3.0T for body applications, and specifically
for cardiac applications, has been somewhat slower.
The slower acceptance of 3.0T for cardiac applications
is due to the unique challenges posed by cardiac ima-
ging: the requirement of a large field of view, the motion
of the heart, the position of the heart within the body,
the proximity of the heart to the lungs, and high radio-
frequency (RF) power deposition required in many high
speed cardiac imaging sequences [4-8].
There are several advantages which motivate users to
perform cardiovascular magnetic resonance (CMR) at a
higher magnetic field strength. First, the bulk magnetiza-
tion increases as the magnetic field strength is increased.
The increased magnetization results in a theoretical
increase in the signal-to-noise ratio (SNR) that is linearly
related to field strength [9-11]. Second, increasing the
magnetic field strength increases frequency separation of
off-resonance spins. Therefore, the frequency difference
between various hydrogen-based compounds is
increased. The enhanced frequency differences may be
exploited for improvement in spectroscopic imaging and
potentially in fat suppression. A third difference that may
be seen as an advantage is that increasing the main mag-
netic field increases the T1 of many tissues, with a negli-
gible effect on the T2 [12-16]. The increase in T1 can
have beneficial effects in some applications such as myo-
cardial tagging and myocardial perfusion sequences, but
requires attention to timing parameters in other
sequences, such as late gadolinium enhancement.
There are challenges to routinely performing CMR at
3.0T. The homogeneity of the main magnetic field (B0)
becomes more critical at 3.0T as off-resonance effects
become important in many imaging sequences. The RF
power deposition required for a given flip angle goes up
with the square of the main magnetic field strength, so
RF power deposition becomes an important considera-
tion in imaging [11,17]. Additionally, maintaining the
homogeneity of the field generated by the RF pulse (B1)
is more of a challenge at 3.0T. Finally, signal loss from
susceptibility-based artifacts becomes more prominent
at 3.0T. From a practical standpoint, many implants that
have been tested and deemed “MR compatible” at 1.5T
have not been examined at 3.0T.
The purpose of this paper is to: 1) outline the physical
effects that occur when increasing the main magnetic
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any medium, provided the original work is properly cited.field from 1.5T to 3.0T, 2) outline the practical results
these physical effects have on the major applications of
CMR, and 3) review the technologic advances used to
overcome these physical effects. Specific CMR applica-
tions to be discussed include: cine imaging, MR coron-
ary angiography, myocardial perfusion imaging, late
gadolinium enhancement, and vascular wall imaging.
Background
Physical Effects of Increased Field Strength
For the purpose of this review, we will concentrate on
five major practical consequences of imaging at higher
field strengths: (1) the increase in the signal-to-noise
ratio, (2) the increase in the Larmor frequency, (3) the
changes in relaxation times, (4) the changes in RF
power deposition and specific absorption rate (SAR),
and (5) the greater impact of field inhomogeneity and
susceptibility.
Magnetization and signal-to-noise ratio (SNR)
Certainly, one of the greatest motivations for performing
CMR at 3.0T is the increased signal-to-noise ratio (SNR)
due to the increased bulk magnetization. Since many
cardiac applications have relatively low SNR, the
increase in SNR could enhance the clinical utility of
many CMR applications and potentially enable new
applications. The theoretical gain in SNR going from
imaging at 1.5T to 3.0T is a factor of two. In many
neuro-imaging applications, this increase has been rea-
lized [17]. In cardiac and body applications, the reported
increases in SNR have been application and sequence
dependant. Often, changes in sequence parameters are
required to adapt 1.5T sequences for 3.0T, and these
changes mitigate the expected theoretical increase in
SNR. This is especially true for sequences that require
multiple rapid sequential RF pulses, such as steady-state
free procession (SSFP) sequences. Often, the specific
absorption rate (SAR) limits are exceeded at 3.0T using
the parameter settings employed at 1.5T. To meet the
SAR requirements, modifications of the sequence, such
as a decrease in flip angle (which reduces SNR) or an
increase in repetition time (which increases susceptibil-
ity effects) are required. Reducing the flip angle causes a
“parameter-induced” reduction in SNR. Other effects,
such as RF field inhomogeneity, increased susceptibility,
and changes in T1 at 3.0T cause “physical-induced”
reductions in SNR. These effects will be discussed in
detail in the following sections.
One potential use of the increased SNR seen at 3.0T is
to employ parallel imaging at 3.0T. Parallel imaging
reduces imaging time by using the additional spatial
encoding information provided by multiple receiver coils
to reduce the number of encoding lines needed. How-
ever, the reduced imaging time decreases the SNR by a
factor approximately equal to the square root of the
reduction in acquisition time. For example, a reduction
in scan time of 2 by parallel imaging would cause SNR
to be reduced by at least a factor of or 1.4 times [18].
The increase in SNR gained at 3.0T can be used to off-
set this reduction in SNR seen with parallel imaging
techniques. The pairing of 3.0T and parallel imaging
could reduce scan time by a factor of two with a preser-
vation of SNR at 1.5T values. The higher resonant fre-
quencies at 3.0T have another potential advantage for
parallel imaging. The higher frequencies allow a greater
separation of the coil elements in the frequency domain.
Other possible uses of the SNR increase seen at 3.0T
would be to improve spatial resolution while keeping
SNR values near their 1.5T level, or to increase SNR
above 1.5T levels while keeping total scan time constant.
Larmor and RF Frequency changes
The resonant (or Larmor) frequency changes linearly
with field strength. Therefore, the doubling of the mag-
netic field strength from 1.5T to 3.0T causes a doubling
of the resonant frequency. The increase of the resonant
frequency also increases the separation between the fre-
quencies of individual hydrogen-based compounds. In
clinical cardiac imaging, this increased separation will
lead to a doubling of the frequency difference between
the primary water frequency and the fat frequency. The
increased difference in the fat and water frequency can
cause alterations in the appearance of the so-called
“India-ink” artifact at 3.0T. The India ink artifact is
caused by very low signal in pixels which cross bound-
aries of tissues containing a combination of fat and
water. These pixels experience a signal phase cancella-
tion at certain echo times that make borders around
these tissues appear dark as though they were outlined
in India ink [8,19]. This effect is a function of the repeti-
tion time (TR) and echo time (TE) used in a particular
sequence, and therefore, it may appear in sequences at
3.0T when it was not seen at 1.5T.
The increased separation between fat and water may
also allow for improvement in chemical-shift based fat
suppression at 3.0T, as the frequency of the fat suppres-
sion pulse is farther from the primary water frequency
and therefore the fat suppression pulse is less likely to
inadvertently partially suppress the water signal. Chemi-
cal shift artifacts, where the spatial positions of pixels
containing fat are shifted relative to water containing
pixels, will be more prominent at 3.0T, however, for
most cardiac sequences, the effect is negligible. The
increased frequency separation between hydrogen-based
compounds has significant benefits for proton spectro-
scopy. The increased frequency separation should create
less overlap in peaks in the spectra and therefore enable
better quantification of specific compound concentra-
tions. The increase in SNR will translate to higher spec-
tral peaks relative to the background signal [14,15,20].
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Page 2 of 13The higher resonant frequency at 3.0T requires that
the frequency of the RF excitation pulse change to
match the 3.0T resonant frequency. At these higher
resonant frequencies, significant spatial variations in the
flip angle can be seen at 3.0T that are not seen at 1.5T.
At main magnetic fields strengths of 3.0T and above,
the electrical conductivity and permittivity of the body
tissue as well as the shape of the body significantly affect
the propagation of the magnetic fields. Additionally,
the wavelength of the generated magnetic fields is on
the order of the body’s size. Together these effects cause
the strength of RF field to vary with spatial position.
The effect has been referred to as “field-focusing”,
because flip angles in head images are increased or
“focused” near the center of the field of view. However,
the effects can be quite variable and are not easily pre-
dicted, especially in cardiac imaging [9,21]. These effects
c a nb ei g n o r e da t1 . 5 T ,b u tm u s tb ec o n s i d e r e da t3 . 0 T
and above. Using standard pulses, the resultant flip
angle across the body has been reported to vary by 40%
and the variations are dependant on tissue type [21-24].
Figure 1 shows a CuSO4 bottle phantom at 1.5T and
3.0T after a 90° rf pulse. Much more spatial variation of
the flip angle is seen at 3.0T.
Changes in RF Power and SAR
As a direct result of increasing the main magnetic field
strength, the frequency of the RF pulse increases. The
increase in frequency increases the power required to
c r e a t eag i v e nf l i pa n g l eb yt h es q u a r eo ft h ec h a n g ei n
main magnetic field [9,11]. The specific absorption rate
(SAR) is an estimate of the time-averaged power (either
per gram of tissue or over the whole body), therefore
SAR of a sequence at 3.0T will have four times the SAR
of the identical sequence run at 1.5T. The SAR limits
are set to prevent excessive heating of tissue due to RF
power deposition. SAR cannotb ed i r e c t l ym e a s u r e di n
patients, so scanner manufacturers use computational
models to estimate SAR for specific sequences. These
models may vary between scanners, but 3.0T sequences
will always have significantly higher SAR compared to
sequences run at 1.5T. Practically, this will require
sequences that use high levels of RF power deposition,
such as SSFP, to be modified when implementing them
at 3.0T to avoid exceeding SAR limits. The most com-
mon way to modify a sequence to reduce SAR is to
reduce the flip angle, and reduction of flip angle will
directly affect SNR. The use of variable-rate selective
excitation (VERSE) or other tailored RF pulses can
reduce SAR without directly reducing the flip angle
[25-28]. Increasing TR will also reduce SAR, but
increasing the TR will cause a greater increase in sus-
ceptibility artifacts, as will be discussed below.
Changes in Relaxation Times
Moving from 1.5T to 3.0T changes the T1 relaxation
time in tissues. T1 relaxation times at 3.0T are generally
longer than at 1.5T. Since the vast majority of CMR
sequences have significant T1-weighting, the change in
T1 values will affect image contrast and sequence para-
meters. The T1 of normal myocardium has been shown
to increase between 12% to 42% going from 1.5T to
3.0T, and the T1 of blood has been shown to increase
7% to 40% when moving from 1.5T to 3.0T [12,29].
The variation in reported values is probably due to dif-
ferences in physiology between individuals and differ-
ences in pulse sequences and methodologies used to
measure T1.
In the range of 1.5T to 3.0T, the field dependence of
T1 relaxation times for Gd- c h e l a t e si sq u i t es m a l l
[30,31]. Therefore, the T1 differences between 1.5T and
3.0T for blood that exist in the pre-contrast state are
negligible early after contrast infusion [12]. The combi-
nation of longer T1’s in most tissues at 3.0T and the
relatively small effects of field strength on Gd-chelate’s
relaxivity create an advantage for T1-weighted contrast
Figure 1 The field-focusing effect is illustrated in a phantom image. Relative signal intensity profiles (ξ) are shown as a function of position
(x) in a CuSO4 bottle. On the left is a signal intensity profile for a 90° flip angle in a 1.5T scanner. Signal intensity is fairly uniform across the
bottle. On the right is a signal intensity profile for a 90° flip angle in a 3.0T scanner. Signal intensity is focused at the center of the bottle.
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longer T1 in static tissue at 3.0T allows for greater
background tissue suppression at 3.0T compared to
1.5T. The T1 reduction in the blood with high levels of
Gd-chelates at 3.0T is preserved at 1.5T. This net effect
of preserved shortening of blood T1 and improved back-
ground suppression is independent of SNR increases;
this is one of the factors responsible for the excellent
results seen for MRA at 3.0T [32].
Changes in T2 values at 3.0T are negligible for most
tissues allowing minimal protocol changes for morpho-
logic T2 spin-echo imaging [29]. However, T2* changes
become increasingly significant at 3.0T for commonly
used gradient-echo cardiac sequences. The reduction in
T2* going from 1.5T to 3.0T is a factor of two, suggest-
ing a linear dependence of T2* on field strength. More
susceptibility artifacts have been reported with T2*-
weighted imaging at 3.0T [33]. The reduction of T2*
can be exploited at 3.0T in several ways. First, the blood
oxygenation level dependant (BOLD) contrast is based
on T2* effects and several studies have shown that the
BOLD effect is increased at 3.0T compared to 1.5T
[34,35]. Secondly, imaging of iron-based contrast agents
has been shown to be more sensitive at 3.0T compared
to 1.5T due to the role of iron on T2* relaxation,
(greater iron concentration causes greater regional signal
dephasing and signal loss) [34]. Third, T2* sensitivity to
iron at 3.0T may be exploited to better delineate indivi-
duals with iron-overload as seen in patients with Thalas-
semia [36,37]. However, the quantification of actual T2*
values in areas of very high iron concentration may be
more difficult at 3.0T due to the very rapid decay of the
signal [33].
Field Homogeneity and Susceptibility
The differences in magnetic susceptibilities of adjacent
tissues cause local alterations in the main magnetic field.
The magnetic field alterations due to susceptibility differ-
ences are a complex function of the local geometry, but
are linearly related to the main magnetic field strength
[11]. Increasing the magnetic field strength from 1.5T to
3.0T causes a linear increase in the susceptibility induced
field variations [38,39]. These field perturbations will be
most prominent at locations where there is a large differ-
ence in magnetic susceptibility between tissues, such as
the myocardial-lung interface, or areas near the coronary
sinus that contain de-oxygenated blood [39,40]. The var-
iations in the main magnetic field due to susceptibility
differences cause a change in the phase of the MR signal.
These local phase changes duet os u s c e p t i b i l i t yd i f f e r -
ences manifest themselves as signal loss in the image. In
a gradient-echo sequence, the phase shift is linearly pro-
portional to the susceptibility difference as well as the
echo time (TE). In SSFP sequences, the phase shift is lin-
early proportional to the susceptibility difference and the
repetition time (TR). Since TR > TE, the susceptibility
induced signal loss artifacts are more prevalent in SSFP
sequences, Figure 2.
The appearance and location of banding artifacts in
SSFP images is also affected by field strength and sus-
ceptibility differences. The banding artifacts occur at
specific frequencies where there is a positive to negative
phase transition of the signal. In areas where susceptibil-
ity differences cause variations in the main magnetic
field, banding artifacts can appear. At 3.0T, the suscept-
ibility effect is greater and hence banding artifacts will
be more prevalent. Since the susceptibility differences
are proportional to field strength, SSFP sequences at
3.0T in areas where tissue susceptibility differences are
large are particularly prone to artifacts. For CMR, a pro-
minent location for signal loss and banding artifacts is
the infero-lateral wall of the myocardium at the lung/
diaphragm interface.
Results
CMR Applications at High Field Strengths
Cine Imaging of Cardiac Function
The use of balanced steady-state free precession (SSFP)
imaging has become the cornerstone for cardiac func-
tional analysis with MRI at 1.5T. SSFP provides signifi-
cant improvements in SNR and CNR over standard
segmented cine gradient-echo methods. At 1.5T, SSFP is
less sensitive to inflow and turbulence-related flow voids
Figure 2 Short-axis, SSFP images acquired at four different repetition times (TR’s), ranging from 2.3msec (far left) to 5.0msec (far
right). As TR is increased, artifacts due to susceptibility and field inhomogeneity are seen in the RV (yellow arrow), at the diaphragm (orange
arrow), is and of the anterior and lateral walls of myocardium (white arrows).
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mentation of SSFP at 3.0T is feasible with promising
results shown by several groups [41-46], it remains an
ongoing challenge to overcome the sensitivity of SSFP
to high field-related artifacts.
SNR and CNR
Reproducible image quality for cine SSFP is important for
robust evaluation of ventricular function, and with modi-
fications to a 1.5T SSFP sequence, high quality functional
cine images can be achieved at 3.0T. In comparison to
1.5T, cine SSFP has shown increased SNR for myocar-
dium and blood at 3.0T, as well as increased blood-to-
myocardium CNR. Increases in CNR have varied widely
from 9.4% to 86% [41,42]. The differences in reported
values are due to differences in acquisition parameters,
the extent of shimming, coil positioning, the patient
groups studied, and placement of ROI for signal mea-
surements. Due to the potential greater variation in flip
angles across the image and the greater effect of suscept-
ibility at 3.0T, it is important to describe the variability of
myocardium SNR segmentally, and between slices.
Comparative analyses of LV function indexes, mass,
and volume using cine SSFP has shown no significant
difference in values obtained at 3.0T compared to 1.5T
[47,48]. Therefore, one can use existing knowledge and
experience of MR quantification algorithms for 3.0T
imaging. Compared to 1.5T, CNR between blood and
myocardium is reduced in the RV at 3.0T relative to
LV, which may affect reproducibility of RV functional
evaluation [47].
Frequency, Relaxation Time, Homogeneity, and
Susceptibility
One of the most commonly seen artifact in 3.0T SSFP
imaging is a “dark-band” artifact described earlier. Dark
band locations are related to the local field inhomogene-
ities and the sequence TR. For similar TR’s, heightened
local field inhomogeneities at 3.0T may cause the dark
bands to come into close proximity of the imaging
region-of-interest, potentially resulting in severe image
deterioration. Reducing TR widens the band spacing,
alleviating the presence of dark bands in the image,
insomuch that concurrent increases in bandwidth and
SAR are tolerable. A fast, frequency-scout acquisition
can be utilized to determine the optimal resonance fre-
quency offset to incorporate with SSFP imaging [49,50].
This “frequency scout” offers a visual indication of the
resonance offset to be employed, but it requires an
additional acquisition, which adds to exam time. A fre-
quency offset based on the frequency scout image,
usually on the order of +/- 200Hz, shifts dark band
artifacts away from the imaging region-of-interest. Alter-
natively, overcoming local field inhomogeneity with a
higher-order shim routine offers the clearest benefits to
high quality cine SSFP imaging at 3.0T [44]. Use of a
shim routine based on a field map of the heart com-
bined with a frequency scout acquisition has shown
excellent results. Other methods to address banding
artifacts on cine SSFP at 3.0T are being investigated,
such as wideband SSFP, which uses sequence adaptation
to widen the spacing between dark bands without reso-
nance frequency modification [50].
The use of fast, segmented, spoiled gradient echo
(GRE) imaging is prevalent in cardiac imaging, with
applications including late gadolinium enhancement
imaging, perfusion imaging and MR angiography. After
the development of SSFP, use of GRE for functional eva-
luation has been limited to specific applications, such as
quantitative flow imaging and regional detection of flow
turbulence and regurgitation. Since the SNR of cine
GRE imaging relies predominantly on the steady-state
T1 signal of blood and myocardium, there will presum-
ably be reduced SNR at 3.0T for identical pulse
sequences due to lengthening of T1 relaxation times.
Although this has been revealed experimentally [41], the
resulting contrast-to-noise ratio and overall image qual-
ity of GRE has been shown to improve at 3.0T com-
pared to 1.5T when using optimized sequences [45].
Cine GRE imaging benefits from its relative insensitivity
to field inhomogeneity artifacts in comparison to SSFP.
This makes imaging of cardiac function with GRE a reli-
able option at 3.0T. However, unbalanced gradient
rephasing and inflow phenomena may lead to transient
signal and flow voids within the ventricle [51]. The use
of standard GRE sequences at 3.0T has been examined
in the presence of an extra cellular gadolinium-based
contrast agent. Hamdan et al showed that long-axis
image quality improved after contrast infusion, but short
axis images did not improve. The improvement in image
quality in the long axis images was due to a reduction in
in-plane flow dephasing artifacts. Differences in LV
volumes and EF’s were also seen between pre-and post-
contrast scans. The differences were due to differences
in the conspicuity of trabeculae and papillary muscles
before and after contrast [51].
Myocardial Tagging
Myocardial “tagging” is a method in which RF pulses
and gradients are used to pre-saturate magnetization
perpendicular to the slice plane prior to cine imaging.
This pre-excitation pulse suppresses magnetization
locally to create “tag lines”, so that regional contractile
motion can be visualized over the cardiac cycle. Tag
lines can be created in a radial, line, or grid pattern.
This technique allows the quantification of myocardium
strain using computer-assisted programs to track the
displacement of tag intersection points over the cardiac
cycle. Since the saturated magnetization in the tag line
is subject to T1 relaxation over the course of the cardiac
cycle, the tag lines gradually fade by diastole. This tag
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myocardium is approximately 800-900ms, which is on
the order of one cardiac cycle. At 3.0T, this tag fading is
lessened since T1 is longer, allowing tag lines to persist
over more of the cardiac cycle. Initial reports have
shown improvement of tag line persistence in the LV by
37% [42]. The tag line persistence is complemented by
improved SNR and CNR of the cine gradient echo
acquisition. These qualitative improvements at 3.0T
t r a n s l a t ed i r e c t l yt oi m p r o v e dq u a n t i t a t i v ea n a l y s i so f
myocardial tagging, allowing better detection of tag lines
and better depiction of epicardial and endocardial bor-
ders for processing multi-directional strain, Figure 3.
Implementation of myocardial tagging has also been
done using SSFP imaging for signal readout, but applica-
tion at 3.0T has been limited [52-54].
It is now clear from multiple studies that significant
increases in SNR and CNR are gained when performing
cine imaging at 3.0T. However, when using SSFP ima-
ging at 3.0T, the presence of artifacts due to susceptibil-
ity and banding are more prevalent compared to 1.5T.
Strategies to quickly and easily reduce the artifacts are
needed for 3.0T SSFP imaging to completely replace
1.5T imaging on a widespread basis.
MR Coronary Angiography
MR coronary angiography is challenging at any field
strength, as the small vessel size and motion of the
heart necessitate rapid imaging and high spatial resolu-
tion. At 1.5T, coronary angiography suffers from SNR
limitations. Imaging at 3.0T could potentially mitigate
these SNR concerns. The increased SNR at 3.0T com-
bined with parallel imaging have caused renewed inter-
est in using a 3 D volume that covers the whole heart in
a single scan, making it possible to visualize the entire
coronary tree [55-57]. Voxel sizes 50% smaller than
those employed at 1.5T have been implemented at 3.0T
with preserved image quality [58]. Alternately, voxel
sizes can be kept at 1.5T sizes and the increased SNR
available at 3.0T can be used solely to reduce image
acquisition time with parallel imaging [59].
SNR and CNR
Several studies have shown that imaging of the coronary
arteries is feasible at 3.0T. These studies have been con-
ducted using a variety of different pulse sequences
including segmented gradient echo (GRE) sequences
[55,57,58,60,61], fast spin echo sequences [62], and
recently, SSFP sequences [63,64]. There have been two
studies directly comparing non-contrast coronary angio-
graphy images acquired at 1.5 and 3.0T. Both these stu-
dies have demonstrated improved SNR and CNR after
moving to 3.0T. Yang et al reported an average SNR
increase of 47% and a CNR increase of 36% when mov-
ing from 1.5 to 3.0T using a high-resolution interleaved
spiral GRE sequence [65]. Bi et al reported SNR and
CNR increases of 87% and 83% respectively when mov-
ing from 1.5T to 3.0T using a high-resolution three-
dimensional multislab SSFP sequence, although greater
image artifacts were also observed at 3.0T [66].
A few reports have examined contrast-enhanced cor-
onary angiography at 3.0T although a direct comparison
with 1.5T has not been done. In a study of 9 healthy
volunteers, Bi et al used a three-dimensional, inversion
recovery prepared GRE sequence during contrast infu-
sion [55]. A 53% increase in SNR and a 305% increase
in CNR was observed compared to a comparable non-IR
prepared sequence acquired without contrast [55]. In
addition, the mean measured length of both the LAD
and the RCA was significantly greater in the contrast-
enhanced images. Kotys et al described a bilateral sha-
dowing artifact along the margins of the coronary
arteries when using a high relaxivity contrast agent at
3.0T. Delaying acquisition until the contrast agent has
reached steady-state and imaging with the more time
efficient centric radial order gave optimal contrast
enhancement, but lead to overestimation of the vessel
width [67], Figure 4.
Frequency, Relaxation Time, Homogeneity, and
Susceptibility
The greater spectral separation of fat and water may
enable more efficient fat-suppression pulses at 3.0T
which may improve coronary imaging. Since signal from
fatty tissue surrounding the coronaries is often sup-
pressed using a frequency-selective, fat-suppression
pulse [68], the greater spectral separation between fat
Figure 3 Tagging images acquired in systole and mid-diastole
at 3.0T and 1.5T. Note that in diastole tag lines have faded more
at 1.5T than at 3.0T. The reduced fading at 3.0T is due to the
prolonged T1 at 3.0T. The longer lasting tag lines may allow for
better analysis of diastolic function at 3.0T. Signal-to-noise is also
higher in the 3.0T images.
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onary arteries by more efficiently suppressing the fat sig-
nal around the vessels. Alternately, the better spectral
selectivity can be used to shorten the duration of the
spectrally-selective contrast preparation pulse. This will
reduce sequence TE and minimize susceptibility artifacts
and T2* signal loss in the images [59,65].
RF field inhomogeneity at 3.0T can cause local
enhancements in signal intensity in different regions.
This local brightening has been observed in coronary
MRA scans, depending on the coils used [66]. One pos-
sible solution for reducing such signal variation is to use
adiabatic RF pulses that are designed to reduce B1 inho-
mogeneities [66].
Main magnetic field inhomogeneity is more pro-
nounced at 3.0T than 1.5T especially when imaging
over a large volume such as is done in whole heart cor-
onary MRA. Volumetric shimming over the heart can
mitigate inhomogeneity effects at 3.0T [68]. To generate
greater magnetic field uniformity, a higher order volu-
metric shim calibration, followed by a dynamic, real-
time, multi-slice linear shim to individually fine-tune the
shim for each slice before image acquisition can be used
[59]. Greater than 40% reductions in magnetic field
inhomogeneities have been demonstrated when higher
order shimming was applied (average RMS field devia-
tion decreased from 61.2+/-3.2 Hz without shimming to
16.5+/-1.3Hz when higher-order terms were used) [69].
Susceptibility artifacts increase at 3.0T due to shorter
T2* and greater field inhomogeneities, and these arti-
facts may obscure coronary vessels along the heart-lung
interface [65]. In a direct comparison of MR coronary
angiography at 1.5 and 3.0T, Yang et al noted suscept-
ibility artifacts were present in 9/23 subjects at 3.0T, but
in none of the subjects at 1.5T [65]. Use of the shortest
TE and readout gradients possible can help reduce the
effects of susceptibility artifacts [59,65]. Furthermore,
careful shimming can further reduce susceptibility arti-
facts [56]. It is important to note that although suscept-
ibility artifacts were more prevalent at 3.0T in the
previously mentioned study, overall image quality for all
the coronary segments was actually higher at 3.0T [65].
At 1.5T, three-dimensional SSFP imaging is the pre-
ferred method for the imaging of the coronary arteries
[68]. However, SSFP techniques cannot be directly
translated to 3.0T as the higher frequencies of the RF
pulses mean that SAR limits are reached much more
rapidly. To implement SSFP sequences at 3.0T, flip
angles must be adjusted and/or repetition times
increased. Obtaining consistent results when imaging
the coronary arteries using SSFP sequences have proved
difficult at 3.0T due to the high sensitivity of SSFP to
off-resonance artifacts, and it has been suggested that
better image quality may be obtained more consistently
by using a spoiled GRE sequence instead of SSFP
[60,61].
3.0T has caused renewed interest in MR coronary
angiography and improvements in coronary imaging
have been seen at 3.0T compared to 1.5T. The optimi-
zation of coronary imaging at 3.0T is continuing.
Myocardial Perfusion
Myocardial perfusion imaging is critical in determining
the extent and location of regional ischemia. Recent stu-
dies have shown that myocardial perfusion imaging with
MRI employing a gadolinium-based contrast agent is
comparable to nuclear based techniques such as SPECT
[64,70]. Imaging at 3.0T offers potential benefits for
myocardial perfusion imaging over 1.5T.
SNR and CNR
Since myocardial perfusion imaging requires rapid
acquisition, SNR and CNR are often compromised at
1.5T. Spatial resolution is often sacrificed for temporal
resolution, which can lead to ringing artifacts in the
image that can be misinterpreted as perfusion defects
[56]. Moving from 1.5T to 3.0T theoretically produces a
doubling of SNR, and therefore perfusion imaging at
3.0T may have practical advantages over imaging at
1.5T. The higher SNR at 3.0T can be used to increase
either spatial or temporal resolution or can be applied
to parallel imaging techniques that decrease image
acquisition time [56]. Deciding which is the best choice
will depend on the specific application. Better temporal
Figure 4 Image of the coronary arteries obtained at 3.0T using
a 32-channel coil and employing a targeted 3 D GRE approach.
Pixel resolution is 0.7 × 1.0 × 2.0. The right coronary artery (RCA)
and left circumflex artery (LCX) and branching vessels can easily be
seen. In general, the 3.0T coronary images have superior SNR and
CNR compared to 1.5T.
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Page 7 of 13resolution is critical in stress perfusion studies, so the
added SNR may be best applied to increase the temporal
resolution of stress perfusion studies [70]. Longitudinal
relaxation time (T1) of myocardial tissue increases with
higher field strength and the relaxivity of most gadoli-
nium-based contrast agents does not change greatly
with field strength [56]. This translates into potentially
increased contrast between perfused and non-perfused
myocardial tissue and higher CNR for perfusion images
acquired at 3.0T [56]
Several studies have reported significant increases in
SNR, CNR, and overall image quality for perfusion ima-
ging when moving from 1.5 to 3.0T [42,71]. Gutberlet et
al reported an SNR increase of 109% when moving from
1.5T to 3.0T with a T1-weighted segmented EPI
sequence [42]. Aroz et al reported that SNR increased
from 25+/-8 to 82+/-26 for peak myocardial enhance-
ment during first-pass perfusion imaging when moving
from 1.5T to 3.0T [71]. Plein et al showed that image
quality is comparable to 1.5T when a five-fold kt-SENSE
reduction factor is used at 3.0T [72]. Christian et al
showed in an animal study that SNR and CNR were bet-
ter in perfusion images acquired at 3.0T compared to
those acquired at 1.5T. Correlation between actual flow
assessed with microspheres and absolute blood flow
assessed by MRI was better at 3.0T than 1.5T [73].
However, it is important to note that the SNR and CNR
increases observed between 1.5 and 3.0T depend on the
sequence and specific imaging parameters employed.
Diagnostic accuracy of myocardial stress perfusion ima-
ging for detecting hemodynamically relevant coronary
artery stenosis at 3.0T has been reported as between 84-
86%, which is comparable to previously reported values
of 82-89% at 1.5T [74-76]. Diagnostic accuracy of perfu-
sion imaging for detecting myocardial ischemia between
1.5T and 3.0T has not been directly compared.
Frequency, Relaxation Time, Homogeneity, and
Susceptibility
Most centers performing perfusion imaging at 1.5T use
a non-selective saturation recovery (SR) 90° RF pulse
rather than an inversion recovery (IR) 180° RF pulse to
generate contrast between the hypo-perfused and nor-
mally-perfused tissue. Although more contrast can theo-
retically be generated with an IR pulse, the increased
speed, reduced heart rate dependence, and more consis-
tent slice to slice contrast have made SR imaging the
current standard. Use of SR-based protocols is even
more crucial at 3.0T compared to 1.5T. The regional RF
inhomogeniety due to field focusing at 3.0T will be less
evident in a saturation pulse than an inversion pulse.
Although the effect can also be seen in a saturation
pulse, due to the lower flip angle, the effect will be less
significant. Adiabatic B1-insensitive rotation pulses using
phase cycling (BIR-4) or pulse trains can be used to
increase the spatial homogeneity of the saturation pulse
over the heart [56,77]. A recent study has reported suc-
cessful acquisition of perfusion images at 3.0T using a 3
D gradient echo sequence preceded by a 90° global adia-
batic saturation pulse [78].
The arguments for using a GRE readout versus an
SSFP readout are similar to the arguments for using a
saturation pre-pulse versus an inversion pre-pulse. Most
studies at 1.5T are carried out with a GRE readout,
although good results have also been obtained using a
SSFP readout [79]. The greater susceptibility artifacts of
the SSFP at 3.0T make GRE the usual choice for 3.0T
perfusion imaging.
Perfusion imaging is playing an increasing role in eva-
luation of patients with suspected ischemia undergoing
cardiac MR exams. Use of a saturation recovery
sequence with standard gradient echo readout allows for
the minimization of susceptibility artifacts at 3.0T and
allows one to take advantage of potential SNR and CNR
gains for increased magnetization as well as gains from
the increase in T1 of myocardial tissue.
Late Gadolinium Enhancement
Late Gadolinium enhancement (LGE) imaging is done
using an inversion-recovery (IR) prepared gradient echo
sequence. The sequence depends on T1 recovery after
the inversion pulse to generate contrast between
infarcted myocardium containing gadolinium and nor-
mal tissue. Because the sequence generates image con-
trast based on T1, special attention needs to be paid to
timing parameters when performing LGE at 3.0T. As
with all sequences at 3.0T, there are SNR advantages to
performing LGE at 3.0T.
SNR and CNR
Several studies have compared LGE at 1.5T and 3.0T.
Klumpp, et al compared 20 subjects imaged at 3.0T and a
separate set of 20 subjects imaged 1.5T [80]. All subjects
had chronic MI and there were no differences between the
numbers of segments with LGE in patients imaged at each
field strength. A segmented, IR-prepared, GRE sequence
was used for imaging, and the inversion time (TI) was opti-
mized for each patient using a TI scout sequence [81].
Imaging parameters were otherwise held constant for the
two field strengths, and SNR and CNR were compared.
The study found that SNR in the infarcted region at 3.0T
was increased 1.6 times compared to 1.5T, and CNR
between normal and infarcted myocardium at 3.0T
increased 1.9 times when compared to 1.5T. Huber, et al
studied 10 subjects with chronic MI at both 1.5T and 3.0T
[82]. A single shot, phase-sensitive inversion recovery
(PSIR) sequence was compared at the two field strengths.
A TI scout sequence was used to determine the inversion
time for each patient. In the magnitude images, CNR
between the infarcted and normal myocardium was 2.1
times higher at 3.0T compared to 1.5T. Infarct volume
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significant variation in individual patients. Bauner et al
imaged 15 patients with chronic MI at 1.5T and 3.0T [83].
LGE imaging was done with a segmented, IR-prepared,
GRE sequence and optimal TI time to null myocardium
was determined using a TI scout sequence. SNR of the
infarcted myocardium increased by 1.8 times at 3.0T com-
pared to 1.5T. CNR between infarcted and normal myo-
cardium increased by 2 times at 3.0T compared to 1.5T.
Infarct volume compared well over all subjects, but Bland-
Altman analysis showed some significant differences
between individual patients. Ligabue et al studied 35 con-
secutive patients with acute MI at 1.5T and 3.0T [84]. LGE
imaging was done by an IR-prepared, segmented, GRE
sequence and the TI for nulling myocardium was found by
a Look-Locker sequence. SNR in infarcted myocardium
was increased 3.9 times at 3.0T compared to 1.5T. CNR
was increased 3.3 times at 3.0T compared to 1.5T.
These studies all show that there appears to be a sig-
nificant increase in SNR of infarcted myocardium, and
an increase in CNR between normal and infarcted myo-
cardium. This increase in SNR is specifically due to the
increase in bulk magnetization going from 1.5T to 3.0T.
The majority of studies have used a segmented gradient-
echo technique for readout. Similar increases are seen
using a balanced SSFP readout, but more image artifacts
were reported when the SSFP readout was used [82].
Frequency, Relaxation Time, Homogeneity, and
Susceptibility
The infusion of a gadoliniumc h e l a t eb a s e dc o n t r a s t
agent changes the T1 of the blood and myocardium as a
function of the concentration of the contrast agent in the
tissue. For the clinical doses used, the relaxation time of
the contrast agent dominates over the intrinsic relaxation
time of the blood and perfused tissue. Due to the nearly
field independent T1 relaxation values of gadolinium
chelates in the 1.5T-3.0T range, soon after infusion there
is no difference in relaxation times in the blood pool or
myocardium at 1.5T and 3.0T [12]. However, as the con-
trast agent is cleared from the normal myocardium, the
field dependent T1 difference in the myocardium is again
seen. At 15-40 minutes post-contrast infusion, the T1 of
normal myocardium which has cleared the majority of
the contrast agent is again longer at 3.0T than 1.5T. This
field dependent T1 contrast will cause the inversion
times to null normal myocardium to be longer at 3.0T
than at 1.5T. In a study of subjects with chronic MI,
Klumpp et al found that TI times to null normal myocar-
dium were 260 ± 30 sec at 1.5T and 330 ± 48 sec at 3.0T
[80]. In a study of patients with acute MI, Ligabue et al
found that TI was 330 ± 50 at 1.5T and 375 ± 55 at 3.0T
[84]. These studies indicate there is a lengthening of the
TI time required to null normal myocardium, but the
exact difference between 1.5T and 3.0T will depend on
the contrast agent dose and the time after infusion that
imaging is conducted, as well as the individual physiology
of specific patients. The prolonged T1 of normal myocar-
dium at 3.0T also theoretically increases the available
contrast between infarcted and normal myocardium. The
increased CNR is partly due greater signal recovery in
infarcted myocardium containing the gadolinium chelate
based contrast agent when the inversion time for nulling
normal myocardium is increased. The amount of this
CNR increase will depend on the imaging sequence used,
heart rate, and contrast dose, but this effect may contri-
bute to the higher levels of CNR increase seen in LGE
imaging at 3.0T.
The RF pulse inhomogeneity affects image quality of
L G Ea t3 . 0 Tm o r et h a n1 . 5 T .T h ev a r i a t i o ni nt h ef l i p
angle can cause the inversion pulse to vary across the
myocardium and blood pool, potentially yielding a flip
angle greater than 180° in some parts of the heart or
blood pool and less than 180° in other locations. The
r e s u l to fi n h o m o g e n e o u sR Fp u l s e si si n c o m p l e t es u p -
pression of the myocardium, or spatially varying sup-
pression of the myocardium and blood pool. Use of
tailored RF pulses or adiabatic inversion pulses reduce
this field focusing effect significantly and produce more
spatially homogeneous inversion. As mentioned pre-
viously, the RF power required to produce an inversion
pulse at 3.0T is four times greater than the power
needed to create the inversion pulse at 1.5T. This can
result in increased RF power deposition in the patient.
However, with the long times between inversion pulses
in LGE imaging (1-3 heart beats), the increased power
seldom causes issues with SAR limitations.
In general, LGE at 3.0T has proven to be as effective
as it has been at 1.5T. SNR as well as infarct-to-myocar-
dium contrast are superior at 3.0T, and some inherent
CNR advantages exist for imaging infarcts at 3.0T. The
user must be aware that timing parameters for nulling
myocardium will change at 3.0T.
Vessel wall imaging
Intimal-medial thickness (IMT) has been used as a mar-
ker of risk for adverse cardiovascular events and the
presence of specific plaque components such as necrotic
core has been shown to be important in identifying vul-
nerable plaques. The reduction or progression of IMT
or change in plaque components has been used as an
endpoint for judging the efficiency of pharmacologic
interventional therapies [85,86]. For studies designed to
assess changes in vascular wall thickness in response to
an intervention, image quality, SNR and CNR are
important. Increased SNR, CNR, and image quality lead
to better inter-test and inter-observer reproducibility,
which allows interventions to be evaluated in a smaller
number of subjects, or allows smaller effects to be
observed, figure 5.
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for its effect on increasing reproducibility of vessel wall
area, vessel wall volume, and mean wall thickness mea-
surements. In a study of six healthy volunteers, Kokzo-
glou et al found a 223% increase in SNR for the carotid
wall at 3.0T compared with 1.5T. CNR between the wall
and lumen increased 255%. Imaging was done with a
multi-slice, black-blood, dual-inversion, turbo spin-echo
(TSE) sequence. Both 1.5T and 3.0T scanners were the
same manufacturer, but coil size and imaging parameter
varied slightly between field strengths [87]. In a study of
10 healthy volunteers, Dehnavi et al examined the inter-
test and inter-observer reproducibility of vessel wall area
and total lumen area measurements. The relative error
between repeated scans was 2.6% with interclass correla-
tion of 0.98, a significant improvement over the relative
errors seen at 1.5T [88]. Similar results were seen in a
s t u d yb yS y e de ta lt h a te x a m i n e d1 0s u b j e c t sa t3 . 0 T
who had IMT >0.65 mm by ultrasound. Subjects were
imaged two times using dual-inversion, black-blood, TSE
and using a carotid coil. Inter-class correlation was 0.98
for total vessel volume [81]. A study by Yarnykh et al
examined five healthy subjects and two patients at 1.5T
and 3.0T. The 1.5T and 3.0T MR scanners were made by
the same manufacturer and coils used were similar.
Dual-inversion, black-blood TSE sequences with similar
scan parameters were used at both field strengths. SNR
increased 77 ± 44% for T2-weighted images, and CNR
between the wall and lumen increased 82 ± 46%. No dif-
ference between vessel wall area measurements between
1.5T and 3.0T were noted, suggesting 1.5T and 3.0T can
be used interchangeably in studies [89].
3.0T has also been examined for its ability to improve
plaque component identification compared to 1.5T.
Underhill et al compared the ability of 1.5T and 3.0T to
identify carotid plaque components in 20 subjects with
moderate carotid stenoses. Multiple contrast mechan-
isms were combined to identify plaque components.
Importantly, two signal averages were used at 1.5T, and
o n l yas i n g l es i g n a la v e r a g ew a su s e da t3 . 0 T .D e s p i t e
these differences in number of signal averages, 3.0T
images showed an increase of SNR of ≈20% over 1.5T
images. Morphometric variables such as total vessel wall
area and lumen agreed well between 1.5T and 3.0T,
having inter-class coefficients of 0.88 to 0.96. This study
again suggests 1.5T and 3.0T can be used interchange-
ably for morphometric measurements [90].
A study by Vidal et al imaged eight subjects with IMT
≥ 0.5 mm by ultrasound. Each subject was scanned two
times at each field strength, using T2-weighted, dual
inversion, black-blood sequences. Both 1.5T and 3.0T
scanners were made by the same manufacturer, and the
coils used were virtually identical. The study found a
90% increase in SNR going from 1.5T to 3.0T and a
25% increase in CNR. Although SNR increased, the
study found no improvement in reproducibility at 3.0T
compared to 1.5T with the coefficient of variance being
7.8% and 5.7% respectively. In addition, this study found
that there was a significant difference between vessel
wall volumes measured at 1.5T compared with 3.0T.
Averaged over all 8 subjects, measurements of vessel
wall volume at 1.5T were approximately 10% higher at
1.5T. Data was not presented to assess if this difference
was consistent over all subjects [91].
Increased SNR at 3.0T may improve vessel wall ima-
ging in the aorta. In a study of 32 subjects (20 healthy
volunteers and 12 subjects with cardiac disease), Mar-
oules et al found that SNR increased ≈50% and CNR
increased ≈70%. Differences in mean wall thickness
measurements between 1.5T and 3.0T were not signifi-
cant, even with the addition of parallel imaging at 3.0T.
Roes et al evaluated navigator-echo gated 3 D, dual
inversion recovery, black-blood imaging for determining
aortic wall thickness [92]. Seven healthy subjects were
imaged two times and SNR, CNR, and reproducibility of
vessel wall volume were evaluated. The use of the
respiratory navigator reduced breathing artifacts as evi-
denced by an increase in vessel sharpness for the navi-
gator gated sequence over the non-gated sequence. The
ICC correlation for inter-scan reproducibility was 0.95,
and the CV was 5.8%.
The increased T1 values of blood at 3.0T compared to
1.5T will require a change in the inversion time (TI) in
order to null blood. The required changes can be esti-
mated from T1 measurement of blood at 3.0T.
The use of 3.0T for vessel wall imaging in the carotids
is an area where there is a clear advantage to 3.0T over
1.5T. The increase in field strength yields improved
Figure 5 Image of the carotid artery obtained in a subject with
a thickened wall in the left common carotid artery. The image
was acquired at 3.0T with a four-channel carotid coil. Image quality
as assessed by SNR and CNR is superior to 1.5T images.
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and better identification of plaque components. SAR
may be a problem in some black-blood vascular imaging
sequences due to the large number of 180° pulses used.
Conclusion
Performing CMR studies at 3.0T compared to 1.5T
causes a number of important physical changes. Fore-
most among these changes is an increase in bulk mag-
netization which results in increased SNR. Additionally,
changes in the resonant frequency produce increased RF
power deposition and an increase in inhomogeneities of
the RF excitation field. Changes in the relaxation times
require changes in timing parameters that depend on
T1. The increase in the main field strength causes an
increase in the effect of magnetic susceptibility artifacts.
Several CMR applications have been shown to
improve at 3.0T. The majority of improvements are due
to the increase in SNR, but some improvements are due
to the change in tissue T1 values. Challenges remain to
the widespread use of 3.0T for all cardiac applications.
The major limitations are the increased artifacts seen in
SSFP imaging and the increased SAR of common
sequences. It is important to note that 3.0T protocols
have not had time to be optimized in the way 1.5T pro-
tocols have been over the past 10 years. It is clear that
simply using 1.5T protocol at 3.0T may not yield the
most optimal results. New developments in parallel ima-
ging, new sequence developments, and further protocol
optimization will be required to realize the complete
benefits of CMR at 3.0T.
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